It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

US drug prices have soared over the last several decades, causing, at times, financial hardship for patients and their families, so Cuban says he developed MCCPDC with a simple mission – “to ...

The Mark Cuban Cost Plus Drug Company (MCCPDC) – a public-benefit corporation and online pharmacy that launched ... AbbVie’s list price for Humira currently stands at more than $6,900 ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...

President Trump on Monday fired all three Democrats on the Privacy and Civil Liberties Oversight Board (PCLOB), bringing much ...

Two bills heard in a state Senate committee are designed to lower prices, provide fair competition for independent pharmacies ...

The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...

Early moves by the president raise questions about what direction his second-term policy on drug costs will take.

Magellan Health Services, a leader in the management of behavioral health care, convened a panel of mental health experts to discuss utilization and costs of outpatient mental health drugs.

For new drugs, such as Aduhelm, where no ASP is available, Medicare pays 103 percent of the wholesale acquisition cost—that is, the list price—until ASP data are available. Some legislation has been ...